WCLC 2022 Conference Coverage


 

Lecture Summary - WCLC 2022 on Ipilimumab and Nivolumab in Pretreated Patients With Malignant Pleural Mesothelioma

1 view
September 7, 2022
0 Comments
Login to view comments. Click here to Login
Videos